5AM Venture Management, LLC Long-Term Concentrated

Location: San Francisco, CA

CIK: 0001799883 · Show all filings

Period: Q3 2020 (← Previous) (Next →)

Filing Date: Nov 16, 2020

Total Value: $380M (100.0% shares, 0.0% debt)

Holdings (9)

— Akouos Inc. 27.7%

Value $105M Shares 4,605,784 Est. Cost $22.50 Unrealized —

— Homology Medicines, Inc. 15.6%

Value $59.23M Shares 5,535,919 Est. Cost $20.70 Unrealized —

— Aprea Therapeutics, Inc. 14.0%

Value $53.24M Shares 2,212,654 Est. Cost $45.89 Unrealized —

IDYA IDEAYA Biosciences, Inc. 11.4%

Value $43.5M Shares 3,463,066 Est. Cost $7.13 Unrealized +73.6%

CABA Cabaletta Bio, Inc. 10.5%

Value $39.77M Shares 3,669,263 Est. Cost $11.85 Unrealized -3.0%

— scPharmaceuticals Inc. 7.5%

Value $28.54M Shares 3,831,474 Est. Cost $5.92 Unrealized —

ARVN Arvinas, Inc. 6.2%

Value $23.61M Shares 1,000,000 Est. Cost $29.28 Unrealized -1.0%

CRNX Crinetics Pharmaceuticals, Inc. 5.6%

Value $21.35M Shares 1,362,286 Est. Cost $19.04 Unrealized -19.7%

— Cidara Therapeutics, Inc. 1.5%

Value $5.719M Shares 2,006,511 Est. Cost $3.84 Unrealized —

Ticker	Issuer	Shares	Value	%	Est. Cost	Unrealized	Class	CUSIP
—	Akouos Inc.	4,605,784	$105M	27.7%	$22.50	—	COM	00973J101
—	Homology Medicines, Inc.	5,535,919	$59.23M	15.6%	$20.70	—	COM	438083107
—	Aprea Therapeutics, Inc.	2,212,654	$53.24M	14.0%	$45.89	—	COM	03836J102
IDYA	IDEAYA Biosciences, Inc.	3,463,066	$43.5M	11.4%	$7.13	+73.6%	COM	45166A102
CABA	Cabaletta Bio, Inc.	3,669,263	$39.77M	10.5%	$11.85	-3.0%	COM	12674W109
—	scPharmaceuticals Inc.	3,831,474	$28.54M	7.5%	$5.92	—	COM	810648105
ARVN	Arvinas, Inc.	1,000,000	$23.61M	6.2%	$29.28	-1.0%	COM	04335A105
CRNX	Crinetics Pharmaceuticals, Inc.	1,362,286	$21.35M	5.6%	$19.04	-19.7%	COM	22663K107
—	Cidara Therapeutics, Inc.	2,006,511	$5.719M	1.5%	$3.84	—	COM	171757107